Getein Biotech Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Getein Biotech Inc cash flow conversion efficiency. Based on the latest financial reports, Getein Biotech Inc (603387) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥100.90 Million ≈ $14.76 Million USD) by net assets (CN¥2.80 Billion ≈ $409.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Getein Biotech Inc (2012–2025)

Cash flow conversion efficiency of Getein Biotech Inc from 2012 to 2025. This chart illustrates how Getein Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 603387 live share price for real-time trading data and today's change.

Getein Biotech Inc Cash Flow Conversion Ratio Explained

Getein Biotech Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Getein Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Getein Biotech Inc ranked by their cash flow conversion efficiency. Also see how much is Getein Biotech Inc worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Mama's Creations Inc. NASDAQ:MAMA	0.041x
ECN Capital Corp TO:ECN	-0.057x
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class D IS:KRDMD	0.031x
Innova Captab Limited NSE:INNOVACAP	0.027x
Stingray Group Inc TO:RAY-A	0.116x
Costar Group Co Ltd SHE:002189	0.005x
DBAPPSecurity Co Ltd SHG:688023	0.005x
Wereldhav B-Sicafi BR:WEHB	0.032x

Annual Cash Flow Conversion Efficiency for Getein Biotech Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Getein Biotech Inc from 2012 to 2025. Review 603387 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.86 Billion ≈ $418.42 Million	CN¥392.59 Million ≈ $57.45 Million	0.137x	-11.68%
2024-12-31	CN¥2.72 Billion ≈ $398.16 Million	CN¥423.00 Million ≈ $61.90 Million	0.155x	+27.89%
2023-12-31	CN¥2.74 Billion ≈ $401.13 Million	CN¥333.22 Million ≈ $48.76 Million	0.122x	-32.93%
2022-12-31	CN¥2.66 Billion ≈ $389.91 Million	CN¥482.96 Million ≈ $70.67 Million	0.181x	-4.67%
2021-12-31	CN¥2.27 Billion ≈ $332.76 Million	CN¥432.36 Million ≈ $63.27 Million	0.190x	+105.44%
2020-12-31	CN¥2.00 Billion ≈ $293.25 Million	CN¥185.47 Million ≈ $27.14 Million	0.093x	-31.05%
2019-12-31	CN¥1.68 Billion ≈ $246.08 Million	CN¥225.73 Million ≈ $33.03 Million	0.134x	-0.76%
2018-12-31	CN¥1.38 Billion ≈ $202.40 Million	CN¥187.10 Million ≈ $27.38 Million	0.135x	-19.10%
2017-12-31	CN¥1.15 Billion ≈ $167.95 Million	CN¥191.91 Million ≈ $28.08 Million	0.167x	-63.22%
2016-12-31	CN¥342.96 Million ≈ $50.19 Million	CN¥155.91 Million ≈ $22.82 Million	0.455x	+0.31%
2015-12-31	CN¥268.60 Million ≈ $39.30 Million	CN¥121.73 Million ≈ $17.81 Million	0.453x	-24.02%
2014-12-31	CN¥165.19 Million ≈ $24.17 Million	CN¥98.53 Million ≈ $14.42 Million	0.596x	-16.03%
2013-12-31	CN¥84.06 Million ≈ $12.30 Million	CN¥59.72 Million ≈ $8.74 Million	0.710x	+21.27%
2012-12-31	CN¥40.63 Million ≈ $5.95 Million	CN¥23.80 Million ≈ $3.48 Million	0.586x	--

About Getein Biotech Inc

SHG:603387 China Medical Devices

Market Cap

$631.55 Million

CN¥4.32 Billion CNY

Market Cap Rank

#10739 Global

#2898 in China

Share Price

CN¥8.51

Change (1 day)

-2.41%

52-Week Range

CN¥7.52 - CN¥10.65

All Time High

CN¥21.49